Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Neuropharmacology

Arecoline inhibits catecholamine release from perfused rat adrenal gland

Acta Pharmacologica Sinica volume 27, pages 71–79 (2006)Cite this article

Abstract

Aim:

To study the effect of arecoline, an alkaloid isolated from Areca catechu, on the secretion of catecholamines (CA) evoked by cholinergic agonists and the membrane depolarizer from isolated perfused rat adrenal gland.

Methods:

Adrenal glands were isolated from male Sprague-Dawley rats. The adrenal glands were perfused with Krebs bicarbonate solution by means of a peristaltic pump. The CA content of the perfusate was measured directly using the fluorometric method.

Results:

Arecoline (0.1–1.0 mmol/L) perfused into an adrenal vein for 60 min produced dose- and time-dependent inhibition in CA secretory responses evoked by acetylcholine (ACh) (5.32 mmol/L), 1.1-dimethyl-4-phenyl piperazinium iodide (DMPP) (100 μmol/L for 2 min) and 3-(m-choloro-phenyl-carbamoyl-oxy)-2-butynyl trimethyl ammonium chloride (McN-A-343) (100 μmol/L for 2 min). However, lower doses of arecoline did not affect CA secretion of high K+ (56 mmol/L); higher doses greatly reduced CA secretion of high K+. Arecoline also failed to affect basal catecholamine output. Furthermore, in adrenal glands loaded with arecoline (0.3 mmol/L), CA secretory response evoked by Bay-K-8644 (10 μmol/L), an activator of L-type Ca2+ channels, was markedly inhibited, whereas CA secretion by cyclopiazonic acid (10 μmol/L), an inhibitor of cytoplasmic Ca2+-ATPase, was not affected. Nicotine (30 μmol/L), which was perfused into the adrenal gland for 60 min, however, initially enhanced ACh-evoked CA secretory responses. As time elapsed, these responses became more inhibited, whereas the initially enhanced high K+-evoked CA release diminished. CA secretion evoked by DMPP and McN-A-343 was significantly depressed in the presence of nicotine.

Conclusion:

Arecoline dose-dependently inhibits CA secretion from isolated perfused rat adrenal gland evoked by activation of cholinergic receptors. At lower doses arecoline does not inhibit CA secretion through membrane depolarization, but at larger doses it does. This inhibitory effect of arecoline may be mediated by blocking the calcium influx into the rat adrenal medullary chromaffin cells without the inhibition of Ca2+ release from the cytoplasmic calcium store. There seems to be a difference in the mode of action of nicotine and arecoline in rat adrenomedullary CA secretion.

Download PDF

References

  1. International Agency for Research on Cancer. Betel-quid and areca-nut chewing. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Volume 37. Lyon: IARC; 1985. p 141–202.

  2. Mujumder AM, Kapadi AH, Pendse GS . Chemistry and pharmacology of betel nut Areca catechu Linn. J Plant Crops 1979; 7: 69–92.

    Google Scholar 

  3. Holdsworth DK, Jones RA, Self R . Volatile alkaloids from Areca catechu. Phytochemistry 1998; 48: 581–2.

    CAS  Article  Google Scholar 

  4. Bhonsle RB, Murti PR, Gupta PC . Tobacco habits in India. In: Gupta PC, Hamner JE, Murti PR editors Control of tobaccorelated cancers and other diseases. Bombay: Oxford University Press; 1992. p 25–6.

    Google Scholar 

  5. Molinengo L, Fundaro AM, Cassone MC . Action of a chronic arecoline administration on mouse motility and on acetylcholine concentrations in CNS. J Pharm Pharmacol 1988; 40: 821–2.

    CAS  Article  Google Scholar 

  6. Taylor RF, Al-Jarad N, John LM, Conroy DM, Barnes NC . Betel-nut chewing and asthma. Lancet 1992; 339: 1134–6.

    CAS  Article  Google Scholar 

  7. Trimarchi GR, Germano A, Campo GM, de Luca R, Caputi AP . Changes in urine volume and urinary electrolyte excretion after intracerebroventricular injection of arecoline and hemicholinium-3. Life Sci 1991; 48: 2097–107.

    CAS  Article  Google Scholar 

  8. Mondadore C, Hengerer B, Ducret T, Borkowski J . Delayed emergence of effects of memory-enhancing drugs: implication for dynamics of long-term potentiation. Proc Natl Acad Sci USA 1994; 91: 2041–5.

    Article  Google Scholar 

  9. Raffaele KC, Berardi A, Asthana S, Morris P, Haxby JV, Soncrant TT . Effects of long-term continuous infusion of the muscarinic cholinergic agonist arecoline on verbal memory in dementia of the Alzheimer type. Psychopharmacol Bull 1991; 27: 315–9.

    CAS  PubMed  Google Scholar 

  10. Carey GJ, Costall B, Domeney AM, Gerald PA, Jones DN, Naylor RJ, et al. Ondansetron and arecoline prevent scopolamine-induced cognitive deficits in the marmoset. Pharmacol Biochem Behav 1992; 42: 75–83.

    CAS  Article  Google Scholar 

  11. Riekkinen P Jr, Ridkkinen M, Sirvil J . Cholinergic drugs regulate passive avoidance performance via the amygdala. J Pharmacol Exp Ther 1993; 267: 1484–92.

    CAS  PubMed  Google Scholar 

  12. Fisher SK, Bartus RT . Regional differences in the coupling of muscarinic receptors to inositol phospholipid hydrolysis in guinea pig brain. J Neurochem 1985; 45: 1085–95.

    CAS  Article  Google Scholar 

  13. Freedman SB, Harley EA, Iversen LL . Biochemical measurement of muscarinic receptor efficacy and its role in receptor regulation. Trends Pharmacol Sci 1988; 3: 54–60.

    Google Scholar 

  14. Wallace MA, Claro E . Comparison of serotonergic to muscarinic cholinergic stimulation of phosphoinositide specific phospholipase C in rat brain cortical membranes. J Pharmacol Exp Ther 1990; 255: 1296–300.

    CAS  PubMed  Google Scholar 

  15. Lee HM, Tsai KJ, Lin CH, Huang CL, Tung CS . Arecoline desensitizes carbachol-stimulated phosphatidylinositol breakdown in rat brain cortices. J Neurochem 1998; 70: 1189–98.

    CAS  Article  Google Scholar 

  16. Yang YR, Chang KC, Chen CL, Chiu TH . Arecoline excites rat locus coeruleus neurons by activating the M2–muscarinic receptor. Chin J Physiol 2000; 43: 23–8.

    CAS  PubMed  Google Scholar 

  17. Porsius AJ, Coilffert B, Lambsecht G, Moser CI, Mutschler E . Muscarinic effects of various isoarecaidine esters in sympathetic ganglia. J Auton Pharmacol 1981; 1: 119–26.

    CAS  Article  Google Scholar 

  18. Polinsky RT, Brown RT, Curras MT, Baser SM, Baucom CE, Hooper DR, et al. Central and peripheral effects of arecoline in patients with autonomic failure. J Neurol Neurosurg Psychiatry 1991; 54: 807–12.

    CAS  Article  Google Scholar 

  19. Chu NS . Effects of betel chewing on the central and autonomic nervous systems. J Biomed Sci 2001; 8: 229–36.

    CAS  Article  Google Scholar 

  20. Wakade AR . Studies on secretion of catecholamines evoked by acetylcholine or transmural stimulation of the rat adrenal gland. J Physiol 1981; 313: 463–80.

    CAS  Article  Google Scholar 

  21. Anton AH, Sayre DF . A study of the factors affecting the aluminum oxidetrihydroxy indole procedure for the analysis of catecholamines. J Pharmacol Exp Ther 1962; 138: 360–75.

    CAS  PubMed  Google Scholar 

  22. Tallarida RJ, Murray RB . Manual of pharmacologic calculation with computer programs. 2nd ed. New York: Springer-Verlag; 1987.

    Google Scholar 

  23. Hammer R, Giachetti A . Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterization. Life Sci 1982; 31: 2992–8.

    Article  Google Scholar 

  24. Garcia AG, Sala F, Reig JA, Viniegra S, Frias J, Fonteriz R, et al. Dihydropyridine Bay-K-8644 activates chromaffin cell calcium channels. Nature 1984; 309: 69–71.

    CAS  Article  Google Scholar 

  25. Lim DY, Kim CD, Ahn KW . Influence of TMB-8 on secretion of catecholamines from the perfused rat adrenal glands. Arch Pharm Res 1992; 15: 115–25.

    CAS  Article  Google Scholar 

  26. Goeger DE, Riley RT . Interaction of cyclopiazonic acid with rat skeletal muscle sarcoplasmic reticulum vesicles. Effect on Ca2+ binding and Ca2+ permeability. Biochem Pharmacol 1989; 38: 3995–4003.

    CAS  Article  Google Scholar 

  27. Seidler NW, Jona I, Vegh N, Martonosi A . Cyclopiazonic acid is a specific inhibitor of the Ca2+-ATPase of sarcoplasmic reticulum. J Biol Chem 1989; 264: 17816–23.

    CAS  PubMed  Google Scholar 

  28. Molinengo L, Orsetti M . Dose versus survival time curves in the elevation of “prompt” and “delayed” acute toxicities. J Pharm Pharmacol 1986; 38: 54–6.

    CAS  Article  Google Scholar 

  29. Cena V, Nicolas GP, Sanchez-Garcia P, Kirpekar SM, Garcia AG . Pharmacological dissection of receptor-associated and voltagesensitive ionic channels involved in catecholamine release. Neuroscience 1983; 10: 1455–62.

    CAS  Article  Google Scholar 

  30. Boarder MR, Marriott D, Adams M . Stimulus secretion coupling in cultured chromaffin cells, dependency on external sodium and on dihydropyridine-sensitive calcium channels. Biochem Pharmacol 1987; 36: 163–7.

    CAS  Article  Google Scholar 

  31. Owen PJ, Marriott DB, Boarder MR . Evidence for a dihydropyridine-sensitive and conotoxin-insensitive release of noradrenaline and uptake of calcium in adrenal chromaffin cells. Br J Pharmacol 1989; 97: 133–8.

    CAS  Article  Google Scholar 

  32. Lopez MG, Fonteriz R, Gandia L, de la Fuente M, Villarroya M, Garcia-Sancho J, et al. he nicotinic acetylcholine receptor of the bovine chromaffin cell, a new target for dihydro-pyridines. Eur J Pharmacol Mol Biol 1993; 247: 199–207.

    CAS  Article  Google Scholar 

  33. O'Farrell N, Zigas J, Marley PD . Effect of N- and L-type calcium channel antagonists and (t)-Bay-K-8644 on nerve-induced catecholamine secretion from bovine perfused adrenal glands. Br J Pharmacol 1997; 121: 381–8.

    CAS  Article  Google Scholar 

  34. Suzuki M, Muraki K, Imaizumi Y, Watanabe M . Cyclopiazonic acid, an inhibitor of the sarcoplasmic reticulum Ca2+-pump, reduces Ca2+-dependent K+ currents in guinea-pig smooth muscle cells. Br J Pharmacol 1992; 107: 134–40.

    CAS  Article  Google Scholar 

  35. Wakade AR, Wakade TD . Contribution of nicotinic and muscarinic receptors in the secretion of catecholamines evoked by endogenous and exogenous acetylcholine. Neuroscience 1983; 10: 973–8.

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Pharmacology, College of Medicine, Chosun University, Gwangju, 501-759, Korea

    Dong-yoon Lim & Il-sik Kim

Authors
  1. Dong-yoon Lim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Il-sik Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dong-yoon Lim.

Additional information

Project supported in part by a research grant from Chosun University (2003–4).

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Lim, Dy., Kim, Is. Arecoline inhibits catecholamine release from perfused rat adrenal gland. Acta Pharmacol Sin 27, 71–79 (2006). https://doi.org/10.1111/j.1745-7254.2006.00233.x

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1111/j.1745-7254.2006.00233.x

Keywords

  • arecoline
  • catecholamine secretion
  • adrenal gland
  • nicotine

Search

Advanced search

Quick links